All In Biotech

Drug Trial Radar · NCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Last checked: Nov 20, 2026Latest source record: Apr 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 492 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

492

Actual

Start

Mar 2010

Primary completion

Nov 2012

Study completion Nov 2012

Sponsor

Lead sponsor
CephalonIndustry
Sponsor type
Industry
First posted
Feb 22, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine whether armodafinil treatment, at a dosage of 150 mg/day, is more effective than placebo treatment as adjunctive therapy to mood stabilizers for treatment of adults with major depression associated with bipolar I disorder.

Conditions

  • Depression

Interventions

  • ArmodafinilDrug

    Doses of either 150mg/day or 200 mg/day in tablet form taken orally, once daily in the morning.

  • PlaceboDrug

    Matching Placebo, also in tablet form taken orally, once daily in the morning.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 8 in the Total Score From the 30-Item Inventory of Depressive Symptomatology-Clinician-Rated (IDS-C30)Time frame: Day 0 (baseline), Week 8

Locations

92 sites in 10 countries. Site status is shown where the registry gives one.

  • Birmingham Psychiatry Pharmaceutical Studies, Inc

    Birmingham, Alabama

  • South Coast Medical Associates/SC Clinical Trials, Inc.

    Anaheim, California

  • Comprehensive NeuroScience

    Cerritos, California

  • Sun Valley Behavioral Medical

    Imperial, California

  • North County Clinical Research

    Oceanside, California

  • CNRI Los Angeles LLC

    Pico Rivera, California

  • CNRI-San Diego LLC

    San Diego, California

  • Clinical Innovations Inc.

    Santa Ana, California

  • Schuster Medical Research Institute

    Sherman Oaks, California

  • Stanford University Medical Center

    Stanford, California

  • Viking Clinical Research Center

    Temecula, California

  • Comprehensive NeuroScience

    Washington D.C., District of Columbia

  • Scientific Clinical Research, Inc.

    Aventura, Florida

  • Florida Clinical Research Center

    Bradenton, Florida

  • Clinical Neuroscience Solutions Inc

    Jacksonville, Florida

  • Fidelity Clinical Research

    Lauderhill, Florida

  • Compass Research, LLC

    Orlando, Florida

  • Stedman Clinical Trials, LLC

    Tampa, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Carman Research

    Smyrna, Georgia

  • Hawaii Clinical Research Center

    Honolulu, Hawaii

  • Midwest Center for Neurobehavioral Medicine

    Oakbrook Terrace, Illinois

  • CNS - Comprehensive Neuro Science

    Park Ridge, Illinois

  • Community Research

    Crestview Hills, Kentucky

  • AccelRx Research

    Fall River, Massachusetts

  • Mayo College of Medicine

    Rochester, Minnesota

  • Precise Research Centers

    Flowood, Mississippi

  • CRI Worldwide, LLC

    Mount Laurel, New Jersey

  • Behavioral Medical Research of Brooklyn

    Brooklyn, New York

  • Fieve Clinical Services, Inc.

    New York, New York

  • Medical and Behavioral Health Research

    New York, New York

  • Behavioral Medical Research of Staten Island

    Staten Island, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • North Coast Clinical Trials, Inc.

    Beachwood, Ohio

  • Neuro-Behavioral Clinical Research, Inc

    Canton, Ohio

  • IPS Research Company

    Oklahoma City, Oklahoma

  • Oregon Center for Clinical Investigators, Inc. (OCCI, Inc.)

    Portland, Oregon

  • Lehigh Center for Clinical Research

    Allentown, Pennsylvania

  • Belmont Center for Comprehensive Treatment

    Philadelphia, Pennsylvania

  • FutureSearch Trials of Neurology

    Austin, Texas

Showing 40 of 92 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.